GILD | Gilead Sciences Inc
Category: Biotechnology company
Quick infos Headquarters: Foster City, California, United States Trade prices Volume: 10.4M Market Cap: 78.22B Prev closed: 59.05 Open: 58.44 High: 61.45 Low: 58.18 52 week low: 57.04 52 week high: 85.97 Dividends: Next ER: October 27, 2022 After Market Closes
About the Company Gilead Sciences is an American biopharmaceutical company that discovers, develops and commercializes drugs.
Earnings History Date EPS / Forecast Revenue / Forecast February 7, 2023 October 27, 2022 1.9 / 1.527B / 6.13BBeat! August 2, 2022 1.58 / 1.526.26B / 5.86BBeat! April 28, 2022 2.12 / 1.86.59B / 6.29BBeat! February 1, 2022 0.69 / 1.597.24B / 6.61BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 17, 2022 66.02 65.97 66.89
65.82
6.44M -0.47% Aug 16, 2022 66.33 66.16 66.42
65.65
7.06M 0.18% Aug 15, 2022 66.21 63.85 66.30
63.66
12.38M 5.16% Aug 12, 2022 62.96 62.71 62.99
62.15
4.00M 0.82% Aug 11, 2022 62.45 62.78 63.41
62.37
5.20M -1.09% Aug 10, 2022 63.14 62.49 63.19
62.11
8.25M 1.84% Aug 9, 2022 62.00 61.58 62.05
61.38
5.15M 0.65% Aug 8, 2022 61.60 61.00 61.71
60.81
5.86M 0.83% Aug 5, 2022 61.09 61.79 61.84
60.62
6.04M -1.32% Aug 4, 2022 61.91 62.14 62.99
61.83
5.51M -0.58% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US3755581036 CUSIP: 375558103 Founded:June 1987 Employees:9,000 News
Gilead looks to shift 250,000 square feet in Peninsula campus master plan from office to lab bizjournals.com Nov 2, 2022 5:49 pm
Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates finance.yahoo.com Nov 2, 2022 5:15 pm
FDA rejects Gilead hepatitis delta virus drug already greenlighted in Europe bizjournals.com Nov 2, 2022 4:48 pm Gilead profit tops expectations despite lower COVID drug sales, outlook raised finance.yahoo.com Nov 2, 2022 4:06 pm
Gilead Sciences Announces Third Quarter 2022 Financial Results finance.yahoo.com Nov 2, 2022 4:01 pm
Gilead Sciences stock surges amid earnings beat and analyst upgrades finance.yahoo.com Nov 2, 2022 3:42 pm
Drug/Biotech Stocks' Q3 Earnings on Oct 27: MRK, GILD & More finance.yahoo.com Nov 2, 2022 2:48 pm
Gilead (GILD) Q3 Earnings & Sales Top, Guidance Raised finance.yahoo.com Nov 2, 2022 1:06 pm
MacroGenics strikes deal with Gilead potentially worth more than $1.7B bizjournals.com Nov 2, 2022 1:04 pm
These 2 Growth Stocks Have Potential Catalysts on the Way fool.com Nov 2, 2022 10:30 am
Analysts Turn Bullish On Gilead After Q3 Earnings Surpass Expectations finance.yahoo.com Nov 2, 2022 10:08 am
15 Best Drug Stocks to Buy Now finance.yahoo.com Nov 2, 2022 9:11 am
What Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE Can Tell Us finance.yahoo.com Nov 2, 2022 9:01 am
12 Best Ethical Stocks To Buy Now finance.yahoo.com Nov 2, 2022 9:00 am
Gilead Sciences: Metastatic Breast Cancer Advocate Urges Black People to Join Clinical Trials finance.yahoo.com Nov 2, 2022 9:00 am
Gilead to Present Data Across Viral Hepatitis and Liver Fibrosis at The Liver Meeting® 2022, Reinforcing Gilead as a Leader in Addressing Treatment Needs for People Living With Liver Disease finance.yahoo.com Nov 2, 2022 9:00 am
Gilead Sciences: Gilead's Rashad Burgess Is Advancing Health and Equity in LGBTQ Communities of Color (The Reckoning) finance.yahoo.com Nov 2, 2022 8:55 am
Gilead Presents Real-World and Long-Term Data From HIV Research Programs at HIV Glasgow 2022 finance.yahoo.com Nov 2, 2022 8:30 am
Gilead Sciences, Inc. (NASDAQ:GILD) Looks Just Right finance.yahoo.com Nov 2, 2022 8:01 am
Great week for Gilead Sciences, Inc. (NASDAQ:GILD) institutional investors after losing 1.0% over the previous year finance.yahoo.com Nov 2, 2022 8:00 am GILD Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Sep 14, 2022 0.73 Sep 29, 2022 Jun 14, 2022 0.73 Jun 29, 2022 Mar 14, 2022 0.73 Mar 30, 2022 Dec 14, 2021 0.71 Dec 30, 2021 Sep 14, 2021 0.71 Sep 29, 2021 view more
Key Persons CEO : John F. Milligan, PhD Talk about Gilead Sciences Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Homepage: gilead.com Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.
